Skip to content

AVICENNE Pharma Services

Active
Private limited companyfounded 2025active for 1 yearTweehuizenweg 73, 1200 Sint-Lambrechts-Woluwe, Belgium17 active companies are registered at this addressKBO/BCE: BE 1024.983.063
Summary

AVICENNE Pharma Services has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,358 and a net result of €18,858. Its solvency ranks better than 62% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€42,747total assets 2025
Equity
€20,358
Profit
€18,858
Turnover not published (abbreviated format)
Financial health
71 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Structure
2025 accounts 37 days early
Why 71raises riskFounded in 20251 change of registered office in 24 monthslowers riskLiquidity: current ratio 1.91, cash €30,405Figures for financial year 2025 (filed 24-06-2026)Show the evidence

Checked score

Score 2025
71 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 79% of its sector peers (NACE 47, micro)
Financial strength
Strong
Solvency 73
equity 47.6% of total assets
Liquidity 74
short-term debt 52.4% · cash 71.1%
Profitability 100
return on assets 44.1%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,231 companies, NACE 47, micro)
Last 24 months 08-2026: 3.9% 09-2026: 4.0%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.8%▼ -3.2 percentage points vs 09-2026lowest value
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.91, above the usual 1.5; short-term debt: 52.4% and cash: 71.1% of total assets), but 52.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 62% on solvency, 79% on liquidity and 96% on profitability.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.91, cash €30,405
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed 24-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-06-2026, 37 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
37 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Registered officeRegistered-office move · Director in…
  3. IncorporationAppointment: LASSOUED Haithem (director) ·…

Key points

  • Caution: Among the weakest 19% on equitysector median €237,682 · 12,671 companies €20,358 View
  • Founded 15 months agofounded 01-07-2025 15 months View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€42,747
Profit
€18,858
Solvency
47.6%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
01-07-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
30
Purpose
“L’exploitation d’officines pharmaceutiques, parapharmaceutiques, homéopathiques, de…” (deed in French)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about AVICENNE Pharma Services

What is the company number of AVICENNE Pharma Services?
1024.983.063. In Belgium the VAT number is the company number with BE in front: BE 1024.983.063.
Where is AVICENNE Pharma Services based?
The registered office is at Tweehuizenweg 73, 1200 Sint-Lambrechts-Woluwe.Company details
What does AVICENNE Pharma Services do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of AVICENNE Pharma Services?
Private limited company (BV).
When was AVICENNE Pharma Services founded?
On 01-07-2025.
Is AVICENNE Pharma Services still active?
Yes, AVICENNE Pharma Services is an active enterprise in the KBO register.
What is the turnover of AVICENNE Pharma Services?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is AVICENNE Pharma Services profitable?
In financial year 2025, AVICENNE Pharma Services made a profit of €18,858.
Where can I find the annual accounts of AVICENNE Pharma Services?
AVICENNE Pharma Services filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to AVICENNE Pharma Services

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.